Background pattern
DuoResp Spiromax 160 micrograms/4.5 micrograms inhalation powder

DuoResp Spiromax 160 micrograms/4.5 micrograms inhalation powder

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use DuoResp Spiromax 160 micrograms/4.5 micrograms inhalation powder

Introduction

Package Leaflet: Information for the Patient

DuoResp Spiromax 160micrograms/4.5micrograms inhalation powder

budesonide/formoterol fumarate dihydrate

Read this leaflet carefully before you start using this medicine because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor, pharmacist, or nurse.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
    • If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. See section 4.

Contents of the pack

  1. What is DuoResp Spiromax and what is it used for
  2. What you need to know before you use DuoResp Spiromax
  3. How to use DuoResp Spiromax
  4. Possible side effects
  5. Storage of DuoResp Spiromax
  6. Contents of the pack and further information

1. What is DuoResp Spiromax and what is it used for

DuoResp Spiromax contains two different active substances: budesonide and formoterol fumarate dihydrate.

  • Budesonide belongs to a group of medicines called “corticosteroids” also known as “steroids”. It works by reducing and preventing swelling and inflammation in the lungs, making it easier to breathe.
  • Formoterol fumarate dihydrate belongs to a group of medicines called “long-acting beta2-adrenergic receptor agonists” or “bronchodilators”. It works by relaxing the muscles in the airways. This will help to open up the airways and make it easier to breathe.

DuoResp Spiromax is indicated for use only in adults and adolescents 12 years and older.

Your doctor has prescribed this medicine to treat asthma or chronic obstructive pulmonary disease (COPD).

Asthma

DuoResp Spiromax may be prescribed for asthma in two different ways.

  • You may have been prescribed two asthma inhalers: DuoResp Spiromax and an additional “reliever” inhaler such as salbutamol.
    • Use DuoResp Spiromax every day. This helps to prevent asthma symptoms such as difficulty breathing and wheezing.
    • Use the “reliever” inhaler when you have asthma symptoms to breathe easily again.
  • You may have been prescribed DuoResp Spiromax as a single inhaler for asthma.
    • Use DuoResp Spiromax every day. This helps to prevent asthma symptoms such as difficulty breathing and wheezing.
    • Use DuoResp Spiromax when you need to take extra puffs for relief of asthma symptoms, to breathe easily again, and, if agreed with your doctor, to prevent asthma symptoms (for example, before exercise or when exposed to allergens). You do not need a separate inhaler for this.

Chronic Obstructive Pulmonary Disease (COPD)

COPD is a long-term lung disease of the airways in the lungs, often caused by smoking. Some of its symptoms are difficulty breathing, coughing, chest discomfort, and phlegm production. DuoResp Spiromax can also be used to treat symptoms of severe COPD in adults only.

2. What you need to know before you use DuoResp Spiromax

Do not use DuoResp Spiromax

If you are allergic to budesonide, formoterol fumarate dihydrate, or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor, pharmacist, or nurse before you start taking DuoResp Spiromax if:

  • You have diabetes.
  • You have any lung infection.
  • You have high blood pressure or have ever had any heart problems (including irregular heartbeat, very fast pulse, narrowing of the arteries, or heart failure).
  • You have thyroid or adrenal gland problems.
  • You have low potassium levels in your blood.
  • You have severe liver problems.
  • You drink alcohol regularly.

If you have been taking steroid tablets for asthma or COPD, your doctor may reduce the number of steroid tablets you take when you start using DuoResp Spiromax. If you have been taking steroid tablets for a long time, your doctor may want to do regular blood tests. When reducing the number of steroid tablets, you may not feel well in general, even if your chest symptoms improve. You may notice symptoms such as a stuffy nose or runny nose, weakness, or muscle and joint pain, and rash (eczema). If any of these symptoms bother you or if you notice symptoms such as headache, tiredness, nausea (upset stomach), or vomiting, call your doctor immediately. You may need to take other medicines if you start to have symptoms of allergy or arthritis. Talk to your doctor if you are not sure whether you should continue using DuoResp Spiromax.

Your doctor may consider adding steroid tablets to your usual treatment if you have a disease such as a chest infection or before an operation.

Contact your doctor if you experience blurred vision or other changes in vision.

Children

Do not give this medicine to children under 12 years of age.

Using DuoResp Spiromax with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

In particular, tell your doctor or pharmacist if you are taking any of the following medicines:

  • Betablockers (such as atenolol or propranolol for high blood pressure or heart disease), including eye drops (such as timolol for glaucoma).
  • Oxytocin, which is given to women in labor to induce childbirth.
  • Medicines for a fast or irregular heartbeat (such as quinidine, disopyramide, procainamide, and terfenadine).
  • Medicines such as digoxin, which are often used for heart failure.
  • Diuretics, also known as “water tablets” (such as furosemide), used for high blood pressure.
  • Steroid tablets taken by mouth (such as prednisolone).
  • Medicines containing xanthine (such as theophylline or aminophylline), often used for asthma.
  • Other bronchodilators (such as salbutamol).
  • Tricyclic antidepressants (such as amitriptyline) and the antidepressant nefazodone.
  • Antidepressants such as monoamine oxidase inhibitors and those with similar properties (such as the antibiotic furazolidone and the anticancer agent procarbazine).
  • Phenothiazine antipsychotics (such as chlorpromazine and prochlorperazine).
  • Medicines called “HIV protease inhibitors” (such as ritonavir) for treating HIV infections.
  • Medicines for treating infections (such as ketoconazole, itraconazole, voriconazole, posaconazole, clarithromycin, and telithromycin).
  • Medicines for Parkinson's disease (such as levodopa).
  • Medicines for thyroid problems (such as levothyroxine).

Some medicines may increase the effects of DuoResp Spiromax, so your doctor will monitor you closely if you are taking these medicines (including some for HIV: ritonavir, cobicistat).

If you are in any of these situations or if you are not sure, talk to your doctor, pharmacist, or nurse before using DuoResp Spiromax.

Also, tell your doctor, pharmacist, or nurse if you are going to have a general anesthetic for an operation or dental treatment, to help minimize any risk of interaction with the anesthetic you will be given.

Pregnancy and breastfeeding

  • If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor, pharmacist, or nurse for advice before using DuoResp Spiromax; DO NOT use this medicine unless your doctor tells you to.
  • If you become pregnant while using DuoResp Spiromax, DO NOT stop using DuoResp Spiromax; talk to your doctor immediately.

Driving and using machines

DuoResp Spiromax is unlikely to affect your ability to drive or use tools or machines.

DuoResp Spiromax contains lactose.

Lactose is a type of sugar found in milk. If your doctor has told you that you have an intolerance to some sugars, contact them before taking this medicine.

3. How to use DuoResp Spiromax

Follow the administration instructions for this medication exactly as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.

  • It is essential to use DuoResp Spiromax daily, even if you do not have symptoms of asthma or COPD at that time.
  • If you are using DuoResp Spiromax for asthma, your doctor will want to check your symptoms regularly.

Asthma

DuoResp Spiromax can be prescribed for asthma in two different ways. The amount of DuoResp Spiromax you will use and when you will use it depends on how it has been prescribed for you.

  • If you have been prescribed DuoResp Spiromax and a separate relief inhaler, read the section called “(A) Using DuoResp Spiromax and a separate 'relief inhaler'”.
  • If you have been prescribed DuoResp Spiromax as a single inhaler, read the section called “(B) Using DuoResp Spiromax as a single inhaler for asthma”.

(A) Using DuoResp Spiromax and a separate relief inhaler

Use DuoResp Spiromax every day.This helps prevent asthma symptoms from appearing.

Recommended dose:

Adults (18 years and older)

1 or 2 inhalations (applications) twice a day, administered in the morning and at night.

Your doctor may increase the dose up to 4 inhalations twice a day.

If your symptoms are well controlled, the doctor may ask you to use this medication once a day.

Adolescents (12 years and older)

1 or 2 inhalations twice a day.

The doctor will help you control your asthma and adjust the dose of this medication to the lowest possible to control your asthma. If your doctor believes you need a lower dose than what is available in your DuoResp Spiromax, your doctor may prescribe an alternative inhaler that contains the same active ingredients as your DuoResp Spiromax, but with a lower dose of the corticosteroid. If your symptoms are well controlled, the doctor may ask you to use this medication once a day. However, do not adjust the number of inhalations your doctor has prescribed without talking to them first.

Use the other “relief inhaler” to treat asthma symptoms when they appear.

Always carry the “relief inhaler” with you and use it to relieve sudden attacks of shortness of breath and wheezing (whistling in the chest). Do not use DuoResp Spiromax to treat these asthma symptoms.

(B) Using DuoResp Spiromax as a single inhaler for asthma

Only use DuoResp Spiromax in this way if your doctor tells you to.

Use DuoResp Spiromax every day.This helps prevent asthma symptoms from appearing.

Recommended dose:

Adults and adolescents (12 years and older):

1 inhalation in the morning and1 inhalation at night

or

2 inhalations in the morning

or

2 inhalations at night.

Your doctor may increase the dose to 2 inhalations twice a day.

Also use DuoResp Spiromax as a “relief inhaler” to treat asthma symptoms when they appear and to prevent their appearance (for example, when exercising or exposed to allergens).

  • If you have asthma symptoms, take 1 inhalation and wait a few minutes.
  • If you do not feel better, take another inhalation.
  • Do not take more than 6 inhalations on the same occasion.

Always carry DuoResp Spiromax with you and use it to relieve sudden attacks of shortness of breath and wheezing (whistling in the chest).

Normally, a daily total dose of more than 8 inhalations is not needed. However, your doctor may allow you to take up to 12 inhalations per day for a limited period.

If you regularly need to take 8 or more inhalations per day, make an appointment with your doctor. They may need to change your treatment.

DO NOT use more than 12 inhalations in a total of 24 hours.

If you are exercising and notice asthma symptoms, use DuoResp Spiromax as described here. However, do not use DuoResp Spiromax right before exercising to prevent asthma symptoms from appearing. It is essential to discuss the use of DuoResp Spiromax to prevent asthma symptoms with your doctor; the frequency of exercise or exposure to allergens may have implications for the treatment you have been prescribed.

Chronic Obstructive Pulmonary Disease (COPD)

Recommended dose:

Adults (18 years and older) only:

2 inhalations twice a day, administered in the morning and at night.

The doctor may also prescribe another bronchodilator medication, such as an anticholinergic (such as tiotropium or ipratropium bromide), for your COPD.

Preparing your new DuoResp Spiromax

Before using your new DuoResp Spiromax inhaler for the first time, you must prepare it as follows:

  • Open the aluminum bag by tearing it at the mark on the top and remove the inhaler.
  • Check the dose indicator to see that there are 120 inhalations in the inhaler.
  • Write the date you opened the aluminum bag on the inhaler label.
  • Do not shake the inhaler before using it.

How to take an inhalation

Each time you need to take an inhalation, follow these instructions:

  1. Hold the inhaler with the semi-transparent cap of the mouthpiece with the red wine color at the bottom.

Finger pressing an auto-injection device with red and gray parts on a white background

  1. Open the mouthpiece cap by folding it down until you hear a loud click. The medication is measured actively. The inhaler is ready for use.

Injection device with arrow indicating direction of opening and air outlet, warning not to block

  1. Gently expel all the air (without it being uncomfortable). Do not expel the air through the inhaler.
  1. Place the mouthpiece between your teeth. Do not bite the mouthpiece. Close your lips around the mouthpiece. Be careful not to block the air inlets.

Inhale through your mouth as deeply and forcefully as you can.

Gray inhalation device with red mouthpiece and arrow indicating direction of inhalation

  1. Remove the inhaler from your mouth. You may notice a taste when taking the inhalation.
  1. Hold your breath for 10 seconds or as long as you can without it being uncomfortable.
  1. Then, gently expel the air (but do not expel the air through the inhaler). Close the mouthpiece cap.

Gray applicator device with red button and curved arrow indicating rotation and closure of the device

If you are going to take a second inhalation, repeat steps 1 to 7.

Rinse your mouth with water after each dose and spit it out.

Do not attempt to disassemble the inhaler or remove or twist the mouthpiece cap, as it is fixed to the inhaler and should not be removed. Do not use the Spiromax if it is damaged or if the mouthpiece has come off the Spiromax. Do not open or close the mouthpiece cap unless you are going to use the inhaler.

Cleaning the Spiromax

Keep the Spiromax dry and clean.

If necessary, wipe the Spiromax mouthpiece with a dry cloth or handkerchief after use.

When to start using a new Spiromax

  • The dose indicator tells you how many doses (inhalations) are left in the inhaler, starting from 120 inhalations when it is full and ending with 0 (zero) inhalations when it is empty.

Gray rectangular insulin device with screen showing numbers 118 and 120 and a triangle indicator

  • The dose indicator, located on the back of the device, indicates the number of inhalations left in the form of even numbers. The spaces between the even numbers represent the odd number of inhalations left.
  • When there are 20 inhalations or less until “8”, “6”, “4”, or “2”, the numbers will appear in red on a white background. When the numbers appear in red in the window, consult your doctor and request a new inhaler.

Note:

  • The mouthpiece will continue to make a “click” even if the Spiromax is empty.
  • If you open and close the mouthpiece without administering the inhalation, the dose indicator will still count it as an inhalation. This dose will be stored in the inhaler for when you need to administer the next inhalation. It is impossible to accidentally take extra medication or a double dose in one inhalation.
  • Keep the mouthpiece closed at all times, except when using the inhaler.

Important information about asthma or COPD symptoms

If you notice that you are short of breath or wheezing during the use of DuoResp Spiromax, you should continue using it, but consult your doctor as soon as possible, as you may need additional treatment.

Contact your doctor immediatelyif:

  • You breathe worse or wake up frequently at night with difficulty breathing or wheezing.
  • You notice chest tightness in the morning or if the feeling of tightness lasts longer than usual.

These signs may indicate that your asthma or COPD is not being controlled correctly and that you may need immediatedifferent or additional treatment.

Once your asthma is controlled, your doctor may consider it appropriate to gradually reduce the dose of DuoResp Spiromax.

If you use more DuoResp Spiromax than you should

It is essential to take the dose that your doctor has indicated. Do not exceed the dose that has been prescribed for you without consulting your doctor.

If you use more DuoResp Spiromax than you should, consult your doctor, pharmacist, or nurse.

The most common symptoms that may occur when using more DuoResp Spiromax than you should are tremors, headache, or rapid heartbeat.

If you forget to use DuoResp Spiromax

If you forget to take a dose, do so as soon as you remember. However, do nottake a double dose to make up for forgotten doses. If it is almost time for your next dose, simply take the next dose at the usual time.

If you notice that you are wheezing or short of breath, or if you notice any other symptom of an asthma attack, use your “relief inhaler”and go to the doctor.

If you stop treatment with DuoResp Spiromax

Do not stop using the inhaler without talking to your doctor first.

If you have any other questions about the use of this medication, ask your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

If you notice any of the following symptoms, stop using DuoResp Spiromax and consult your doctor immediately:

Rare side effects: may affect up to 1 in 1,000 people

  • Swelling of the face, especially around the mouth (tongue and/or throat, and/or difficulty swallowing) or hives along with difficulty breathing (angioedema) and/or sudden feeling of fainting. This may indicate that you are having an allergic reaction, which can also include rash and itching.
  • Bronchospasm (constriction of the muscle of the airways that causes wheezing and difficulty breathing). If wheezing appears suddenly after using this medication, stop using it and consult your doctor immediately(see below).

Very rare side effects: may affect up to 1 in 10,000 people

  • Sudden, unexpected, and severe wheezing and/or shortness of breath immediately after using the inhaler (also called “paradoxical bronchospasm”). If any of these symptoms occur, stop using DuoResp Spiromax immediatelyand use the “relief inhaler”, if you have one. Consult your doctor immediately, as you may need to change your treatment.

Other possible side effects:

Common: may affect up to 1 in 10 people

  • Palpitations (awareness of your own heartbeat), tremors, or agitation. If these effects occur, they are usually mild and will disappear as you continue using DuoResp Spiromax.
  • Thrush (a fungal infection) in the mouth. This is less likely to occur if you rinse your mouth with water after using the medication.
  • Mild sore throat, cough, and hoarseness.
  • Headache.
  • Pneumonia (lung infection) in patients with COPD.

Tell your doctor if you experience any of the following symptoms while inhaling DuoResp Spiromax; they could be symptoms of a lung infection:

  • Fever or chills
  • Increased production of mucus, change in the color of the mucus
  • Increased cough or increased difficulty breathing

Uncommon: may affect up to 1 in 100 people

  • Feeling of restlessness, nervousness, agitation, anxiety, or anger.
  • Sleep problems.
  • Feeling of dizziness.
  • Nausea (upset stomach).
  • Rapid heartbeat.
  • Bruising.
  • Muscle cramps.
  • Blurred vision

Rare:

  • Low levels of potassium in the blood.
  • Irregular heartbeat.

Very rare:

  • Depression.
  • Changes in behavior, especially in children.
  • Chest pain or tightness (angina pectoris).
  • Alteration of the heart's electrical system that does not cause symptoms (prolongation of the QTc interval).
  • Increased amount of sugar (glucose) in the blood when a blood test is done.
  • Alterations in the perception of taste, such as an unpleasant taste in the mouth.
  • Changes in blood pressure.

Inhaled corticosteroids may affect the body's normal production of steroid hormones, especially if used in high doses for prolonged periods. Among their effects are:

  • Changes in bone mineral density (weakening of the bones)
  • Cataracts (clouding of the eye's lens)
  • Glaucoma (increased pressure in the eye)
  • Slowing of the growth rate in children and adolescents
  • Effects on the adrenal gland (small gland located next to the kidney). Symptoms of adrenal gland suppression may include fatigue, weakness, stomach upset including nausea, vomiting, pain, and diarrhea, darkening of the skin, and weight loss.

These effects occur very rarely and are much less likely to occur with inhaled corticosteroids than with tablets.

Reporting side effects

If you experience any side effects, consult your doctor, pharmacist, or nurse, even if they are possible side effects not listed in this leaflet. You can also report them directly through the national reporting system included in Appendix V. By reporting side effects, you can help provide more information on the safety of this medication.

5. Storage of DuoResp Spiromax

  • Keep this medication out of the sight and reach of children.
  • Do not use this medication after the expiration date that appears on the box or on the inhaler label after EXP. The expiration date is the last day of the month indicated.
  • Do not store above 25°C. Keep the mouthpiece cap closed after removing the laminated wrapper.
  • Use it within 6 monthsof opening the laminated wrapper. Use the inhaler label to note the date you opened the package.
  • Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of the packaging and any unused medication. This will help protect the environment.

6. Container contents and additional information

DuoResp Spiromax composition

  • The active substances are budesonide and formoterol fumarate dihydrate. Each administered dose (inhaled) contains 160 micrograms of budesonide and 4.5 micrograms of formoterol fumarate dihydrate. This is equivalent to a measured dose of 200 micrograms of budesonide and 6 micrograms of formoterol fumarate dihydrate.
  • The other component is lactose monohydrate, which contains milk proteins (see section 2, subsection "DuoResp Spiromax contains lactose").

Appearance of DuoResp Spiromax and container contents

DuoResp Spiromax is an inhalation powder.

Each DuoResp Spiromax inhaler contains 120 inhalations and is white in color, with a semi-transparent red wine-colored cap for the mouthpiece.

Packaging of 1, 2, and 3 inhalers. Only some package sizes may be marketed in your country.

Marketing authorization holder

Teva Pharma B.V.,

Swensweg 5, 2031GA Haarlem, Netherlands.

Manufacturer

Norton (Waterford) Limited T/A Teva Pharmaceuticals Ireland

Unit 27/35, IDA Industrial Park, Cork Road, Waterford, Ireland

Teva Pharmaceuticals Europe B.V., Swensweg 5, 2031 GA Haarlem, Netherlands

Teva Operations Poland Sp. z o.o. Mogilska 80 Str. 31-546 Kraków Poland

You can request more information about this medication by contacting the local representative of the marketing authorization holder:

Belgium

Teva Pharma Belgium N.V./S.A./AG

Tel: +32 3 820 73 73

Luxembourg

Teva Pharma Belgium N.V./S.A./AG

Belgium

Tel: +32 3 820 73 73

Bulgaria

Teva Pharmaceuticals EAD

Tel: +359 2 489 95 85

Hungary

Teva Gyógyszergyár Zrt

Tel: +36 1 288 64 00

Czech Republic

Teva Pharmaceuticals CR, s.r.o.

Tel: +420 251 007 111

Malta

Teva Pharmaceuticals Ireland

Ireland

Tel: +44 207 540 7117

Denmark

Teva Denmark A/S

Tlf: +45 44 98 55 11

Netherlands

Teva Nederland B.V.

Tel: +31 800 0228 400

Germany

Teva GmbH

Tel: +49 731 402 08

Norway

Teva Norway AS

Tlf: +47 6677 55 90

Estonia

UAB Teva Baltics Eesti filiaal

Tel: +372 661 0801

Austria

ratiopharm Arzneimittel Vertriebs GmbH

Tel: +43 1 97007 0

Greece

Specifar A.B.E.E.

Tel: +30 211 880 5000

Poland

Teva Pharmaceuticals Polska Sp. z o.o.

Tel: +48 22 345 93 00

Spain

Teva Pharma S.L.U.

Tel: +34 91 387 32 80

Portugal

Teva Pharma - Produtos Farmacêuticos Lda

Tel: +351 21 476 75 50

France

Teva Santé

Tél: +33 1 55 91 7800

Romania

Teva Pharmaceuticals S.R.L

Tel: +4021 230 6524

Ireland

Teva Pharmaceuticals Ireland

Tel: +44 207 540 7117

Slovenia

Pliva Ljubljana d.o.o.

Tel: +386 1 58 90 390

Iceland

Alvogen ehf.

Tel: +354 522 2900

Slovakia

Teva Pharmaceuticals Slovakia s.r.o.

Tel: +421 2 5726 7911

Italy

Teva Italia S.r.l.

Tel: +39 028 917 981

Finland

Teva Finland Oy

Tel: +358 20 180 5900

Cyprus

Specifar A.B.E.E.

Greece

Tel: +30 211 880 5000

Sweden

Teva Sweden AB

Tel: +46 42 12 11 00

Latvia

UAB Teva Baltics filiale Latvija

Tel: +371 67 323 666

United Kingdom(Northern Ireland)

Teva Pharmaceuticals Ireland

Ireland

Tel: +44 207 540 7117

Lithuania

UAB Teva Baltics

Tel: +370 5 266 02 03

Croatia

Pliva Hrvatska d.o.o

Tel: +385 1 37 20 000

Date of last revision of this leaflet: May 2021

Other sources of information

Detailed information on this medication is available on the European Medicines Agency website: http://www.ema.europa.eu.

About the medicine

How much does DuoResp Spiromax 160 micrograms/4.5 micrograms inhalation powder cost in Spain ( 2025)?

The average price of DuoResp Spiromax 160 micrograms/4.5 micrograms inhalation powder in October, 2025 is around 39.56 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.

Get updates and exclusive offers

Be the first to know about new services, marketplace updates, and subscriber-only promos.

Follow us on social media
FacebookInstagram
Logo
Oladoctor
Find a doctor
Doctors by specialty
Services
Choose language
© 2025 Oladoctor. All rights reserved.
VisaMastercardStripe